| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 02/04/2010 | WO2010013846A1 New therapeutic agent for malignant mesothelioma and immunostimulant |
| 02/04/2010 | WO2010013495A1 Pharmaceutical composition containing highly purified botulinum neurotoxin therapeutic agent as active ingredient, and use thereof |
| 02/04/2010 | WO2010013204A1 Composition for regenerating senescent cutaneous and sub-cutaneous tissue, products and uses thereof |
| 02/04/2010 | WO2010013143A2 Methods for inhibiting mast cell activation and treating mast cell-dependent inflammatory diseases and disorders using lactobacillus |
| 02/04/2010 | WO2010012972A2 Novel bacterial cells and uses thereof |
| 02/04/2010 | WO2010012852A1 Use of bacteria of the genus tenacibaculum for quorum quenching |
| 02/04/2010 | WO2010012408A2 Microemulsion |
| 02/04/2010 | WO2010012127A1 Use of a traditional chinese medicinal composition for preparing medicine for promoting bone marrow-derived mesenchymal stem cell survival in vivo and cardiac muscle differentiation |
| 02/04/2010 | WO2010012088A1 Apparatus and method for loading and transporting containers |
| 02/04/2010 | WO2010012077A1 Compositions, methods and kits for reprogramming somatic cells |
| 02/04/2010 | WO2010012025A1 Amnion epithelial cells for the treatment of degenerative disc disease |
| 02/04/2010 | WO2009147453A9 Production method of blood that can be given to anyone & classic derivatives of white/red line preparation of special-use pre-enriched product |
| 02/04/2010 | US20100029747 Methods and compositions for inhibiting the function of polynucleotide sequences |
| 02/04/2010 | US20100028460 Improvements in relation to cancer therapy |
| 02/04/2010 | US20100028455 Nutritional supplement |
| 02/04/2010 | US20100028450 Tolerogenic biodegradable artificial antigen presenting system |
| 02/04/2010 | US20100028449 Fermented milk product and use thereof |
| 02/04/2010 | US20100028434 Temperature controlled and pH dependent self gelling biopolymeric aqueous solution |
| 02/04/2010 | US20100028422 Pharmaceutical Compositions and Methods for Treating or Preventing Oxalate-Related Disease |
| 02/04/2010 | US20100028408 Method for sterilizing unheated raw honey, a honey-based wound care preparation, a wound care treatment product, and a biscuit based on honey |
| 02/04/2010 | US20100028407 Layered bio-adhesive compositions and uses thereof |
| 02/04/2010 | US20100028405 Matrix, cell implantation and method for their production and use |
| 02/04/2010 | US20100028401 Stem cell source for promoting neovascularisation |
| 02/04/2010 | US20100028398 Cell implantation to prevent and/or treat hearing loss |
| 02/04/2010 | US20100028387 Biocompatible Coated Nanostructured Titanium Surfaces |
| 02/04/2010 | US20100028377 Recombinant RSV Virus Expression Systems And Vaccines |
| 02/04/2010 | US20100028374 C-type lectin transmembrane antigen expressed in human prostate cancer and uses therof |
| 02/04/2010 | US20100028366 Synergistic effect between a cyanogenic system and another oxidative inducing system for treating tumors |
| 02/04/2010 | US20100028349 activates FGF receptors, regulates the growth and differentiation of cells within the liver, regulates other cell types following secretion from the liver, plays a role in liver chemotaxis, has an oncogenic activity, or serves as an antigen for generating antibodies; treating diabetes or obesity |
| 02/04/2010 | US20100028327 Novel low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis |
| 02/04/2010 | US20100028313 Compositions and methods for treatment of skin disorders |
| 02/04/2010 | US20100028312 Stably transformed bone marrow-derived cells and uses thereof |
| 02/04/2010 | US20100028311 Using of scaffold comprising fibrin for delivery of stem cells |
| 02/04/2010 | US20100028310 Composition for Transplantation Comprising Adipose Stem Cells or Adipocytes |
| 02/04/2010 | US20100028309 Method for directed cell in-growth and controlled tissue regeneration in spinal surgery |
| 02/04/2010 | US20100028307 Pluripotent stem cell differentiation |
| 02/04/2010 | US20100028306 Amnion-Derived Cell Compositions, Methods of Making and Uses Thereof |
| 02/04/2010 | US20100028302 Use of IGFBP-2 in Senescence Diseases and for the Maintenance of Organ Functions |
| 02/04/2010 | US20100028263 Methods for inhibiting mast cell activation and treating mast cell-dependent inflammatory diseases and disorders using lactobacillus |
| 02/03/2010 | EP2149382A1 Dentinogenesis promoter and dentinogenic pulp-capping material |
| 02/03/2010 | EP2149381A2 Method of treating malignancies through induction of blood immune responses |
| 02/03/2010 | EP2148887A2 Oriented collagen-based materials, films and methods of making same |
| 02/03/2010 | CN201394205Y Device for coating Ankahuangmin capsule pellets |
| 02/03/2010 | CN201393824Y Multifunctional healthcare pillow |
| 02/03/2010 | CN101641109A Reduction of risk of diarrhoea |
| 02/03/2010 | CN101641108A Melanogenesis inhibitory composition |
| 02/03/2010 | CN101641107A A method for preparing materials having antithrombotic activity from muskrat musk and materials obtained from the method |
| 02/03/2010 | CN101641106A Anti-TSG101 antibodies and their uses for treatment of viral infections |
| 02/03/2010 | CN101637480A Chinese medicinal composition for treating leg cramps |
| 02/03/2010 | CN101637479A Snake oil ointment |
| 02/03/2010 | CN101637478A Use of oviductus ranae in preparing medicament for curing and preventing diseases caused by immunologic dysfunction |
| 02/02/2010 | US7655771 Polymorphisms in the human cyp3a4 and cyp3a7 genes and their use in diagnostic and therapeutic applications |
| 02/02/2010 | US7655628 Method for treating liver cirrhosis or interstitial pulmonary fibrosis |
| 02/02/2010 | US7655616 Traumatic brain and spinal cord injury treatment; administering interleukin-1B converting enzyme (capsase-1) inhibitor |
| 02/02/2010 | US7655465 Also melanocyte stem cells and to their use in cell replacement therapies including skin grafts, hair transplantation strategies, and tissue engineering |
| 02/02/2010 | US7655459 Enhancer contains interleukin as an effective component and is co-administered with a recombinant herpes simplex virus that selectively replicates in cancer cells |
| 02/02/2010 | US7655260 Antibiotic-free animal feed containing colloidal silver andfish cartilidge powder; health-promoting for livestock including mink, poultry and pigs; plasmacytosis, puppy disease, enteritis virus, three-day sickness and/or "sticky" kits in mink; immunocompetance; veterinary medicine |
| 02/02/2010 | US7655226 Treatment of Pompe's disease |
| 02/02/2010 | US7655225 Methods of expanding stem and progenitor cells and expanded cell populations obtained thereby |
| 02/02/2010 | US7655224 Neural stem cells and use thereof for brain tumor therapy |
| 02/02/2010 | CA2453518C Nucleic acid-free bacterial ghost preparation formed by co-expression of lytic and nuclease genes |
| 02/02/2010 | CA2445356C Biocompatible scaffolds for ligament or tendon repair |
| 02/02/2010 | CA2436752C Bifidobacteria and preparations containing them |
| 02/02/2010 | CA2366468C Anti-human mitochondrial adenylate kinase isozyme antibody, diagnostic formulation and diagnostic kit for cardiac disease |
| 02/02/2010 | CA2320929C Continuous magnetic separation of components from a mixture |
| 02/02/2010 | CA2302779C Recombinant mhc molecules useful for manipulation of antigen-specific t-cells |
| 01/28/2010 | WO2010011960A2 Triple acting antimicrobials that are refractory to resistance development |
| 01/28/2010 | WO2010011611A2 Antimicrobially-primed medicinal maggot therapy |
| 01/28/2010 | WO2010011352A2 Compositions for mesoderm derived isl1+ multipotent cells (imps), epicardial progenitor cells (epcs) and multipotent cxcr4+cd56+ cells (c56cs) and methods of use |
| 01/28/2010 | WO2010011315A2 Proteins for use in diagnosing and treating infection and disease |
| 01/28/2010 | WO2010011185A1 Stem cells obtained through in vitro culture with heparan sulfate |
| 01/28/2010 | WO2010011161A1 Method for producing live cell vaccine for preventing mammary cancer |
| 01/28/2010 | WO2010010948A1 Protection against norovirus infection or removal of norovirus by using substance associated with blood type |
| 01/28/2010 | WO2010010887A1 Tissue expression promoter |
| 01/28/2010 | WO2010010364A2 Process for the purification of oils |
| 01/28/2010 | WO2010010172A2 Glycolipid fraction from cyanobacteria for treatment of diseases of the oral cavity |
| 01/28/2010 | WO2010010021A1 Probiotics to increase iga secretion in infants born by caesarean section |
| 01/28/2010 | WO2010009573A1 A pharmaceutical composition for regulating the potassium channel in cardiac muscle cell and its preparation method and its uses |
| 01/28/2010 | WO2010009511A1 A collagen scaffold for cell growth and a method for producing same |
| 01/28/2010 | US20100023124 Biological nasal bridge implant and method of manufacturing |
| 01/28/2010 | US20100022940 Percutaneously Introduceable Shunt Devices and Methods |
| 01/28/2010 | US20100022005 Adipose stromal stem cells for tissue and vascular modification |
| 01/28/2010 | US20100021576 Bacillus Amyloliquefaciens K317 for Suppressing the Growth of Antibiotics-Resistant Pathogenic Microorganism or Enteropathogenic Microorganism |
| 01/28/2010 | US20100021555 Compositions containing high omega-3 and low saturated fatty acid levels |
| 01/28/2010 | US20100021545 Injectable in situ self-forming mineral-polymer hybrid composition and uses thereof |
| 01/28/2010 | US20100021533 Nutritional supplement for the prevention of cardiovascular disease, alzheimer's disease, diabetes, and regulation and reduction of blood sugar and insulin resistance |
| 01/28/2010 | US20100021521 Prosthesis for joint cartilage repair and method of manufacture |
| 01/28/2010 | US20100021504 Treatment and prevention of allergic airways diseases |
| 01/28/2010 | US20100021500 Processes for treating subjects carrying viral infectious agent |
| 01/28/2010 | US20100021468 Novel mhc class ii restricted t cell epitopes from the cancer anitgen, ny eso-1 |
| 01/28/2010 | US20100021467 Method of detecting a cancer cell by aberrant expression of a human k+ ion channel |
| 01/28/2010 | US20100021455 Methods for diagnosis and treatment of crohn's disease |
| 01/28/2010 | US20100021447 Medicament for Treating Problems Relating to Fertility and Pregnancy, and Autoimmune Diseases, and for Inducing an Immunological Tolerance in Transplant Patients, and Method for Producing Said Medicament |
| 01/28/2010 | US20100021446 Use of Polypeptides Against Diseases Caused by Protozoans |
| 01/28/2010 | US20100021445 Agent for reducing visceral fat |
| 01/28/2010 | US20100021444 Blood-adiponectin-concentration increase-accelerator and/or decrease-inhibitor thereof and visceral fat accumulation inhibitor |
| 01/28/2010 | US20100021443 Method of preparing lung alveolar epithelial type ii cells derived from embryonic stem cells |
| 01/28/2010 | US20100021442 Method for promoting immunotherapy using an agent for elevating dendritic cell precursor level in blood |
| 01/28/2010 | US20100021441 Mhc molecule-binding tumor-associated peptides |
| 01/28/2010 | US20100021440 Use of tropoelastin for repair or restoration of tissue |